The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
Manassas, VA · On-site
$120K - $140K/yr
Experience with new approach methodologies (NAMs), microphysiological systems (MPS), organoids, organ-on-chip technologies, or related advanced cellular model platforms. * Demonstrated ability to ...
Manassas, VA · On-site
$120K - $140K/yr
Experience with new approach methodologies (NAMs), microphysiological systems (MPS), organoids, organ-on-chip technologies, or related advanced cellular model platforms. * Demonstrated ability to ...
Manassas, VA · On-site
$120K - $140K/yr
Experience with new approach methodologies (NAMs), microphysiological systems (MPS), organoids, organ-on-chip technologies, or related advanced cellular model platforms. * Demonstrated ability to ...
Manassas, VA · On-site
$120K - $140K/yr
Experience with new approach methodologies (NAMs), microphysiological systems (MPS), organoids, organ-on-chip technologies, or related advanced cellular model platforms. * Demonstrated ability to ...
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
New
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico ...
| Aspect | Microphysiological | Cell Culture Technician |
|---|---|---|
| Required Credentials | Typically requires a degree in biology, biomedical engineering, or related fields | Often requires a degree or certification in biology or laboratory techniques |
| Work Environment | Research labs, biotech companies, pharmaceutical testing facilities | Laboratories, research institutions, biotech companies |
| Industry Usage | Used in drug testing, disease modeling, tissue engineering | Used in cell growth, maintenance, and preparation for experiments |
Microphysiological roles focus on creating complex tissue models that mimic human organs, often requiring advanced technical skills. Cell Culture Technicians primarily handle cell growth and maintenance. While both roles involve laboratory work and biological expertise, Microphysiological positions typically demand more specialized knowledge in tissue engineering and organ-on-chip systems.

North Bethesda, MD
Part-time
Posted 3 days ago
New
The Director, New Approach Methodologies (NAMs) for toxicology and drug development, will lead the strategy, development, and execution of multi-sector scientific partnerships to advance, validate, and qualify innovative alternative models for drug development and human safety toxicity testing. These efforts will be under the banner of the NAMs Validation and Qualification Network (VQN) that is currently being stood up as a pillar to the Complement Animal Research in Experimentation (Complement-ARIE) Consortium facilitated by the National Institutes of Health (NIH). The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico, and ex vivo, and the goal will be to drive these NAMs to a state of readiness for acceptance by the appropriate regulatory body.
This role sits at the intersection of translational science, regulatory science, and collaborative innovation. The Director will work closely with biopharmaceutical, chemical, agrichemical, and comestics companies, regulatory agencies, academic investigators, and patient-focused organizations to accelerate the adoption of scientifically robust, fit-for-purpose models that improve predictive safety assessment and drug development and reduce reliance on traditional animal testing. This position will report to the Senior Vice President of Translational Science within the Science Partnerships department and is based at the FNIH offices located in North Bethesda, MD.
The ideal candidate brings deep expertise in preclinical drug development and toxicology, paired with the ability to lead complex, precompetitive collaborations, and design projects that will move toward regulatory acceptance.
Key Responsibilities
Scientific & Program Leadership & Portfolio Management
Develop and lead a strategic portfolio of programs focused on NAMs for drug development and human safety/toxicity assessment
Identify high-impact use cases where NAMs can be developed precompetitively for validation and qualification for regulatory agencies, including FDA, EMA, EPA, and others in the US and globally
Facilitate group creation of scientific frameworks for model validation, context of use (COU) definition, and evidentiary standards
Design, launch, and manage multi-partner collaborations across industry, academia, government, and nonprofits
Build trusted relationships with biopharma, chemical, agrichemical, and cosmetics R&D leaders, regulatory scientists, and academic innovators
Regulatory Science & Qualification Pathways
Lead efforts to align validation strategies with regulatory expectations (e.g., FDA, EMA, PMDA, EPS, OECD, etc.)
Translate emerging science into regulatory-ready, validated models for submission to the relevant qualification programs (e.g., iSTAND, ENTRÉE, OECD, etc.)
Program Oversight & Delivery
Ensure rigorous governance of all of the VQN and each precompetitive project developed
Aid the VQN project leads on milestone tracking and financial stewardship
Lead cross-functional workstreams including internal staff and external partners to address key needs in the NAMs validation and qualification space
Field Building & Thought Leadership
Represent the organization in scientific and policy forums and partner interactions
Contribute to publications and consensus frameworks that advance the field
Compensation details: 185000-225000 Yearly Salary
PIe9baed0f3516-38003-40185326
Sourced by ZipRecruiter
Non-profits
11 - 50 Employees
North Bethesda, MD, US
1990